The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder

Non-Hodgkin’s Lymphomas, Version 2.2014

(2017) Andrew D. Zelenetz et al.   Journal of the National Comprehensive Cancer Network

Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders

(2013) J. Morscio et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Post-Transplantation Lymphoproliferative Disorder After Kidney Transplantation: Report of a Nationwide French Registry and the Development of a New Prognostic Score

(2013) Sophie Caillard et al.   JOURNAL OF CLINICAL ONCOLOGY

Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

(2013) Catherine M. Bollard et al.   JOURNAL OF CLINICAL ONCOLOGY

Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors

(2013) Daan Dierickx et al.   LEUKEMIA & LYMPHOMA

T-cell therapy in the treatment of post-transplant lymphoproliferative disease

(2012) Catherine M. Bollard et al.   Nature Reviews Clinical Oncology

The Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders

(2012) Denis Glotz et al.   TRANSPLANTATION

Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★

(2011) R. Reshef et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

(2011) E. Doubrovina et al.   BLOOD

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

(2011) Ralf Trappe et al.   LANCET ONCOLOGY

Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines

(2010) Anne Parker et al.   BRITISH JOURNAL OF HAEMATOLOGY

Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era

(2010) Andrew M. Evens et al.   JOURNAL OF CLINICAL ONCOLOGY

Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation

(2009) M. T. van Leeuwen et al.   BLOOD

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

(2009) H. E. Heslop et al.   BLOOD

Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy, and Survival at a Transplantation Center

(2009) Jason S. Knight et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction

(2009) H. Omar et al.   Transplant Infectious Disease

Prospective Study of Sequential Reduction in Immunosuppression, Interferon Alpha-2B, and Chemotherapy for Posttransplantation Lymphoproliferative Disorder

(2009) Lode J. Swinnen et al.   TRANSPLANTATION

EBV PCR in the Diagnosis and Monitoring of Posttransplant Lymphoproliferative Disorder: Results of a Two-Arm Prospective Trial

(2008) D. E. Tsai et al.   AMERICAN JOURNAL OF TRANSPLANTATION

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER